Key Record Dates
ClinicalTrials.gov Identifier: | NCT04540185 |
---|---|
Brief Title: | A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831) |
First Submitted : | September 4, 2020 |
First Submitted that Met QC Criteria : | September 4, 2020 |
First Posted : | September 7, 2020 |
Last Update Submitted that Met QC Criteria : | September 5, 2020 |
Last Update Posted : | September 9, 2020 |